The identification of human occludin as an essential host partner in cell entry spotlights the central role of the tight junction in HCV infection and brings us one step closer to a mouse model of ...

Finally, although HCV is an RNA virus that does not produce ... the emergence of viral escape mutants to both antibody and T-cell responses, it is very likely that additional mechanisms are ...

Atea Pharmaceuticals, Inc. (Nasdaq: AVIR) (Atea or Company), a clinical-stage biopharmaceutical company engaged in the ...

Julie Sheldon, a scientist at the Institute for Experimental Virology and first author of the study, has already investigated HCV variants that were better adapted to human cell cultures.

Cells stimulated with core, E1 and E2 protein, core peptides, or vaccinia poly HCV. Unstimulated or empty vaccinia stimulated cells were used as a negative control. PMA/ION stimulated cells were ...

the researchers analyzed the immune cells in the blood of four patients with HCV-triggered cryoglobulinemic vasculitis. They identified the specific rogue clone B cells that were present in large ...

Please provide your email address to receive an email when new articles are posted on . HCV screening increased after guidelines updated to screen all adults and during each pregnancy. Screening ...

The arrival of interferon-free, orally administered direct-acting antivirals (DAAs) in 2014 was a leap forward for the treatment of hepatitis C (HCV), a disease responsible for some 700,000 deaths ...

Results Patients with hepatitis B (HBV) were more likely to develop HCC at a younger age than patients with hepatitis C (HCV) (HBV-26% under age 40, HCV-0% under age 40; p < 0.001), with greater ...

but not HCV. Those with higher chances of getting HBV should get vaccinated. That includes people who have HIV, inject illicit drugs, or are health care workers. To help prevent Merkel cell ...